Skip to search.
 TSX Up 0.16% TSX Ventures Up 0.38%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
512.34 Up 15.92(3.21%) 3:02PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:496.42
Open:503.71
Bid:508.12 x 100
Ask:508.97 x 100
1y Target Est:617.48
Beta:1.04311
Earnings Date:Nov 2 - Nov 6 (Est.)
Day's Range:493.77 - 512.95
52wk Range:320.06 - 605.93
Volume:414,538
Avg Vol (3m):758,751
Market Cap:54.13B
P/E (ttm):129.25
EPS (ttm):3.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 3.21%54.13B
AMGNUp 1.72%113.73B

Key Statistics

Forward P/E (1 yr):34.25
P/S (ttm):15.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :12.23
Quarterly EPS Est (Sep-15) :3.13
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.86

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback